DJIA 16,027.05 -177.92 -1.10%
NASDAQ 4,283.75 -79.39 -1.82%
S&P 500 1,853.44 -26.61 -1.42%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

82.00 -4.61 (-5.32%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRTX $82.00 -5.32%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $85.23
Previous Close $86.61
Daily Range $79.81 - $85.85
52-Week Range $79.81 - $143.45
Market Cap $20.1B
P/E Ratio -37.49
Dividend (Yield) $0.00 (0.0%)
Volume 4,215,071
Average Daily Volume 2,747,372
Current FY EPS -$2.28




Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website:

News & Commentary Rss Feed

Vertex Pharmaceuticals Inc.'s Q4 Revenues Surge on New Drug

The biotech's newest drug, cystic fibrosis treatment Orkambi, is now its top-selling asset.

Vertex (VRTX) Down on CRL for Kalydeco Label Expansion

Vertex Pharmaceuticals Has Great Upside Potential

Here's Why Shares Of Vertex Pharmaceuticals Tumbled

Health Care Sector Update for 02/05/2016: JNJ, PFE, ABT, MRK, AMGN, IMMU, VRTX

Health Care Sector Update for 02/05/2016: VRTX, DHRM

Ignore Regeneron Pharmaceuticals, Inc: Here Are 3 Better Buys Right Now

Thinking about investing in Regeneron? Here are three names you might want to consider instead.

Vertex A Buy On Orkambi Revenue And Pipeline

Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date?

3 Key FDA Decisions Expected in February

See More VRTX News...

VRTX's Top Competitors

VRTX $82.00 (-5.32%)
Current stock: VRTX
AMGN $143.00 (-1.41%)
Current stock: AMGN
GILD $85.26 (0.14%)
Current stock: GILD
BIIB $250.77 (-4.96%)
Current stock: BIIB